R.PR
REGISTERED-PRINCIPAL REGISTER
10/19/2021
Back to search
Official data from USPTO
ONCOBAY CLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOBAY CLINICAL
ST13
US500000088872763Class
35, 42, 44
Filing
88872763
Registration
6531654
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
10/19/2021
Trademark type
Word
Nice classes
35, 42, 44
Filing date
04/15/2020
Registration date
10/19/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/19/2021
Last transaction
10/19/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/18/2020
First use in commerce
03/18/2020
Drawing code
4
Owner type
03
Owner location
Tampa, FL
Examiner
DUENAS, TAYLOR
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OncoBay Clinical, Inc.
Representatives
Monica B. Mason, Esq. TRENAM LAW
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Consulting services in the field of medical product approval for commercial purposes
Class 42
Providing contract research organization services in multiple therapeutic areas related to product research and ultimate FDA approval; providing preclinical researchclinical researchclinical trialscomprehensive safety management and reporting in the nature of pharmacovigilanceresearch in the field of pharmaceuticalsbiotechnologymedical devices for pharmaceuticalbiotechnologymedical device companiesto foundationsresearch institutionsuniversitiesgovernmental organizations; research and development of biopharmaceuticalsbiologic assays in the nature of biopharmaceuticals
Class 44
Medical protocol implementation servicescollectingextractinganalyzingmonitoring for accuracy data from electronic health records and case report forms for use in clinical trialscreating statistics there from
Publications
History of USPTO decisions and trademark events.
34 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/17/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/16/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/31/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/30/2021
EX1G
SOU EXTENSION 1 GRANTED
08/30/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/30/2021
IUAF
USE AMENDMENT FILED
08/25/2021
EXT1
SOU EXTENSION 1 FILED
08/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/25/2021
EISU
TEAS STATEMENT OF USE RECEIVED
08/25/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2021
ALIE
ASSIGNED TO LIE
03/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/08/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/08/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
12/08/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
12/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/07/2020
GNRT
NON-FINAL ACTION E-MAILED
07/07/2020
CNRT
NON-FINAL ACTION WRITTEN
07/07/2020
DOCK
ASSIGNED TO EXAMINER
07/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2020
NWAP
NEW APPLICATION ENTERED
04/18/2020
Continuous trademark protection
Get notified about every new filing that threatens ONCOBAY CLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.